Complete case intake
Capture key clinical details, imaging notes, pathology context, and referral intent in one guided flow.
Physician referral and expert board portal
Greek Rare Tumor Board Portal
A secure referral pathway for physicians seeking expert multidisciplinary review of rare sarcoma and rare tumor cases.
Submit structured case referrals, support expert triage, and receive a documented advisory recommendation with relevant evidence and bibliography.
Who can refer
Referrals are intended for verified healthcare professionals involved in the management of rare cancer cases.
- Medical oncologists
- Surgical oncologists
- Radiation oncologists
- Pathologists / molecular diagnostics teams
- Hospital or private oncology teams
Account approval by the coordination team is required before case submission.
Referral scope
Eligible cases should require rare tumor expertise before a diagnostic or therapeutic decision.
| Eligible case type | Typical referral intent | Clarification |
|---|---|---|
| Confirmed or suspected sarcomas | Diagnostic orientation, pathology review, treatment sequencing. | Includes cases where subtype, grade, or optimal treatment sequence is uncertain. |
| Rare or ultra-rare solid tumors | Expert input before major therapeutic decision. | For tumors requiring specialist interpretation beyond routine local pathways. |
| Uncertain or complex diagnosis | Pathology, imaging, and clinical-context review. | Suitable when diagnostic confidence affects treatment planning. |
| Complex molecular findings | Molecular testing / genomic interpretation guidance. | Includes actionable variants, rare fusions, or unclear biomarker significance. |
| Treatment sequencing questions | Surgery, radiotherapy, systemic therapy, or trial orientation. | This portal is not intended for emergency care or direct patient self-referral. |
About RareOnco Greece
A secure physician portal supporting structured referral of rare sarcoma and rare tumor cases to a central expert board / virtual tumor board.
Timely expert triage
Route cases toward appropriate expertise with clear status signals and concise review milestones.
Multidisciplinary review
Support collaboration between referring physicians, national centers, and specialist tumor boards.
What the expert board provides
The board issues an advisory recommendation supported by expert review and relevant bibliography.
- Diagnostic and pathology review orientation
- Molecular testing / genomic interpretation guidance
- Treatment sequencing recommendation
- Surgery, radiotherapy, or systemic therapy planning input
- Clinical trial or research orientation where relevant
- Bibliography / evidence references attached to the report
The recommendation is advisory. The referring clinician remains responsible for final patient management decisions.
How it works
Structured national workflow from referral submission to advisory report and follow-up request. Initially, board meetings may be scheduled approximately monthly, depending on case volume and urgency.
Clinical data, diagnostic evidence, and the referral question are entered through the secure portal.
Required documentation and consent status are reviewed before triage.
A fellow prepares case orientation and relevant evidence references.
Disease-specific experts are identified based on diagnosis, molecular findings, and clinical question.
The case is discussed in a scheduled multidisciplinary board session.
A documented recommendation is issued and follow-up information is requested.
Governance & Security
Designed for accountable clinical collaboration, institutional oversight, and secure handling of sensitive referral information.
Data controller
Greek Sarcoma & Rare Cancers Group.
Patient consent required
Referrers must confirm consent before submitting clinical data for board review.
Coded case identity
Cases use coded Case IDs and limited identifiers to support secure clinical review.
Role-based access
Access is restricted by role for referrers, coordinators, fellows, experts, and administrators.
Audit trail
Submissions, views, board decisions, and recommendations are recorded for accountability.
Advisory model
Recommendations are advisory only. Final patient management remains with the treating clinician.
Connect with RareOnco Greece
For institutional access, referral onboarding, or national center participation, contact the RareOnco Greece coordination team.